Humulin Injection, Solution
NDC Package 0002-0213-01
Package Information
Humulin (insulin human) injection is insulin regular is used with a proper diet and exercise program to control high blood sugar in people with diabetes. This formulation utilizes a injection, solution delivery system. Marketed by Eli Lilly And Company, this product is identified by NDC 0002-0213 and is authorized under FDA application BLA018780.
Identification & Billing
- RxCUI: 311034 - regular insulin, human 100 UNT/ML Injectable Solution
- RxCUI: 311034 - insulin, regular, human 100 UNT/ML Injectable Solution
- RxCUI: 311034 - insulin, human regular 100 UNT/ML Injectable Solution
- RxCUI: 311036 - HumuLIN R 100 UNT/ML Injectable Solution
- RxCUI: 311036 - insulin, regular, human 100 UNT/ML Injectable Solution [Humulin R]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0002 - Eli Lilly And Company
- 0002-0213 - Humulin
- 0002-0213-01 - 1 VIAL, MULTI-DOSE in 1 CARTON / 3 mL in 1 VIAL, MULTI-DOSE
- 0002-0213 - Humulin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0002-0213-01 identifies a specific commercial package of 1 vial, multi-dose in 1 carton / 3 ml in 1 vial, multi-dose of Humulin R, a human over the counter drug labeled by Eli Lilly And Company. This injection, solution is formulated for parenteral use and contains insulin human as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Eli Lilly And Company on June 27, 1983.
What are the primary indications for this medication?
Insulin regular is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a short-acting insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used in combination with a medium- or long-acting insulin product. This medication may also be used alone or with other oral diabetes drugs (such as metformin).
How is this Eli Lilly And Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00002021301. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.